Clinical Trial Update: Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy [NA]

View source ↗

Summary

A completed clinical trial investigating vorinostat in male and recurrent stage IV breast cancer patients undergoing aromatase inhibitor therapy; results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Male Breast Cancer

Drugs mentioned

• Vorinostat (vorinostat)

Snippet

Sponsor: University of Washington | Conditions: Male Breast Cancer, Recurrent Breast Cancer | NA | Status: COMPLETED | Results posted: 2014-11-07